Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma.

Chan OT, Chen ZM, Chung F, Kawachi K, Phan DC, Himmelfarb E, Lin F, Perry A, Wang HL.

Am J Clin Pathol. 2010 Dec;134(6):880-5. doi: 10.1309/AJCPK6QHNNOEMJIM.

PMID:
21088150
[PubMed - indexed for MEDLINE]
Free Article
2.

HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas.

Gu MJ, Hong SM, Jung SJ; Korean Small Intestinal Cancer Study Group.

Virchows Arch. 2013 Jun;462(6):603-7. doi: 10.1007/s00428-013-1425-1. Epub 2013 May 24.

PMID:
23703294
[PubMed - indexed for MEDLINE]
3.

Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?

Park YS, Hwang HS, Park HJ, Ryu MH, Chang HM, Yook JH, Kim BS, Jang SJ, Kang YK.

Hum Pathol. 2012 Mar;43(3):413-22. doi: 10.1016/j.humpath.2011.05.019. Epub 2011 Aug 19.

PMID:
21855114
[PubMed - indexed for MEDLINE]
4.

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.

Liang Z, Zeng X, Gao J, Wu S, Wang P, Shi X, Zhang J, Liu T.

BMC Cancer. 2008 Dec 6;8:363. doi: 10.1186/1471-2407-8-363.

PMID:
19061514
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.

Kanta SY, Yamane T, Dobashi Y, Mitsui F, Kono K, Ooi A.

Hum Pathol. 2006 Oct;37(10):1333-43. Epub 2006 Aug 10.

PMID:
16949920
[PubMed - indexed for MEDLINE]
6.

HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.

Kunz PL, Mojtahed A, Fisher GA, Ford JM, Chang DT, Balise RR, Bangs CD, Cherry AM, Pai RK.

Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):13-24. doi: 10.1097/PAI.0b013e31821c821c.

PMID:
21617522
[PubMed - indexed for MEDLINE]
7.

Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.

Zhan N, Dong WG, Tang YF, Wang ZS, Xiong CL.

Med Oncol. 2012 Jun;29(2):933-40. doi: 10.1007/s12032-011-9850-y. Epub 2011 Feb 13.

PMID:
21318736
[PubMed - indexed for MEDLINE]
8.

[Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].

Liang ZY, Wang WZ, Gao J, Wu SF, Zeng X, Liu TH.

Zhonghua Bing Li Xue Za Zhi. 2007 Feb;36(2):102-6. Chinese.

PMID:
17493384
[PubMed - indexed for MEDLINE]
9.

Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.

Li JW, Chuang TC, Yang AH, Hsu CK, Kao MC.

Int J Oncol. 2005 Apr;26(4):933-43.

PMID:
15753987
[PubMed - indexed for MEDLINE]
10.

Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.

Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P.

Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):1031-6.

PMID:
17938328
[PubMed - indexed for MEDLINE]
11.

Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.

König AM, Reeh M, Dancau AM, Rathjens M, Gros S, Uzunoglu FG, Bockhorn M, Simon R, Sauter G, Marx A, Izbicki JR.

Anticancer Res. 2013 Nov;33(11):4975-82.

PMID:
24222138
[PubMed - indexed for MEDLINE]
12.

Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.

Fleischmann A, Rotzer D, Seiler R, Studer UE, Thalmann GN.

Eur Urol. 2011 Aug;60(2):350-7. doi: 10.1016/j.eururo.2011.05.035. Epub 2011 May 25.

PMID:
21640482
[PubMed - indexed for MEDLINE]
13.

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

Clauditz TS, Reiff M, Gravert L, Gnoss A, Tsourlakis MC, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W.

Pathology. 2011 Aug;43(5):459-64. doi: 10.1097/PAT.0b013e3283484a60.

PMID:
21670724
[PubMed - indexed for MEDLINE]
14.

p95HER2 truncated form in resected non-small cell lung cancer.

Cappuzzo F, Cho YG, Sacconi A, Alì G, Siclari O, Incarbone M, Destro A, Terracciano L, Fontanini G, Marchetti A, Roncalli M, Varella-Garcia M.

J Thorac Oncol. 2012 Mar;7(3):520-7. doi: 10.1097/JTO.0b013e318249e13f. Erratum in: J Thorac Oncol. 2012 Jun;7(6):1065.

PMID:
22307009
[PubMed - indexed for MEDLINE]
15.

HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization: comparison of HercepTest and PathVysion commercial assays.

McCormick SR, Lillemoe TJ, Beneke J, Schrauth J, Reinartz J.

Am J Clin Pathol. 2002 Jun;117(6):935-43.

PMID:
12047146
[PubMed - indexed for MEDLINE]
Free Article
16.

Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung.

Grob TJ, Kannengiesser I, Tsourlakis MC, Atanackovic D, Koenig AM, Vashist YK, Klose H, Marx AH, Koops S, Simon R, Izbicki JR, Bokemeyer C, Sauter G, Wilczak W.

Mod Pathol. 2012 Dec;25(12):1566-73. doi: 10.1038/modpathol.2012.125. Epub 2012 Aug 17.

PMID:
22899293
[PubMed - indexed for MEDLINE]
Free Article
17.

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.

Shan L, Ying J, Lu N.

Diagn Pathol. 2013 May 9;8:76. doi: 10.1186/1746-1596-8-76.

PMID:
23656792
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

Thompson SK, Sullivan TR, Davies R, Ruszkiewicz AR.

Ann Surg Oncol. 2011 Jul;18(7):2010-7. doi: 10.1245/s10434-011-1554-1. Epub 2011 Jan 26.

PMID:
21267790
[PubMed - indexed for MEDLINE]
19.

Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer.

Schindlbeck C, Mayr D, Olivier C, Rack B, Engelstaedter V, Jueckstock J, Jenderek C, Andergassen U, Jeschke U, Friese K.

J Cancer Res Clin Oncol. 2010 Jul;136(7):1029-37. doi: 10.1007/s00432-009-0748-4. Epub 2010 Jan 6.

PMID:
20052594
[PubMed - indexed for MEDLINE]
20.

Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.

Takehana T, Kunitomo K, Kono K, Kitahara F, Iizuka H, Matsumoto Y, Fujino MA, Ooi A.

Int J Cancer. 2002 Apr 20;98(6):833-7.

PMID:
11948459
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk